Freshwater, D., Murphy, N., & Hecker, M. T. (2017). To Add or Not to Add: Would the Addition of Dalbavancin to Formulary Decrease Admissions for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)? Open Forum Infect Dis.
Stile di citazione ChicagoFreshwater, Dustin, Nina Murphy, e Michelle T. Hecker. "To Add or Not to Add: Would the Addition of Dalbavancin to Formulary Decrease Admissions for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)?" Open Forum Infect Dis 2017.
Citazione MLAFreshwater, Dustin, Nina Murphy, e Michelle T. Hecker. "To Add or Not to Add: Would the Addition of Dalbavancin to Formulary Decrease Admissions for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)?" Open Forum Infect Dis 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.